Hypolipidemic action of chrysin on Triton WR-1339-induced hyperlipidemia in female C57BL/6 mice

Toxicology Reports

Volumn 1, Issue , 2014, Pages 200-208

  Zarzecki, Micheli Stéfani ^a   Araujo, Stífani M ^a   Bortolotto, Vandreza C ^a   de Paula, Mariane Trindade ^a   Jesse, Cristiano Ricardo ^a   Prigol, Marina ^a  

^a UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

Author keywords

Chrysin; Female C57BL 6 mice; Hyperlipidemia; Oxidative stress; Triton WR 1339

Indexed keywords

ASCORBIC ACID; CARBONYL DERIVATIVE; CATALASE; CHOLESTEROL; CHRYSIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NON PROTEIN SULFHYDRYL; SIMVASTATIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; TYLOXAPOL; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; FEMALE; HYPERLIPIDEMIA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN DETERMINATION; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 84922007956     PISSN: 22147500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxrep.2014.02.003     Document Type: Article

References (48)

1. Taniguchi H., Yomota E., Nogi K., Onoda Y. Effects of anti-ulcer agents on ethanol-induced gastric mucosal lesion in d-GalN-induced hepatitis rats. Arzneimittelforschung 2002, 52(8):600-604.
2. Repa J.J., Mangelsdorf D.J. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol. 2000, 16:459-481.
3. Sun X., Essalmani R., Day R., Khatib A.M., Seidah N., Prat A. Proprotein convertase subtilisin/kexin type 9 deficiency reduces melanoma metastasis in liver. Neoplasia 2012, 14(December (12)):1122-1131.
4. Woo M.N., Bok S.H., Choi M.S. Hypolipidemic and body fat-lowering effects of fatclean in rats fed a high-fat diet. Food Chem. Toxicol. 2009, 47(August (8)):2076-2082. (Epub 2009 June 14). 10.1016/j.fct.2009.05.041.
5. Collins R., Armitage J., Parish S., Sleight P., Peto R. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360(July (9326)):7-22.
6. Jamal S.M., Eisenberg M.J., Christopoulos S. Rhabdomyolysis associated with hydroxymethylglutarylcoenzyme A reductase inhibitors. Am. Heart J. 2004, 147(June (6)):956-965.
7. Oh P.S., Lee S.J., Lim K.T. Hypolipidemic and antioxidative effects of the plant glycoprotein (36kDa) from Rhus verniciflua stokes fruit in Triton WR-1339-induced hyperlipidemic mice. Biosci. Biotechnol. Biochem. 2006, 70(February (2)):447-456.
8. Kumar S.A., Sudhahar V., Varalakshmi P. Protective role of eicosapentaenoate-lipoate (EPA-LA) derivative in combating oxidative hepatocellular injury in hypercholesterolemic atherogenesis. Atherosclerosis 2006, 189(November (1)):115-122. (Epub 2006 February 3).
9. Uttara B., Singh A., Zamboni P., Mahajan R.T. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 2009, 7(March (1)):65-74. 10.2174/157015909787602823.
10. Ha B.J., Lee S.H., Kim H.J., Lee J.Y. The role of Salicornia herbacea in ovariectomy-induced oxidative stress. Biol. Pharm. Bull. 2006, 29(July (7)):1305-1309.
11. Harnafi H., Caid H.S., Bouanani N.el H., Aziz M., Amrani S. Hypolipemic activity of polyphenol-rich extracts from Ocimum basilicum in Triton WR-1339-induced hyperlipidemic mice. Food Chem. 2008, 108:205-212.
12. Bertges L.C., Mourão CAJr, Souza J.B., Cardoso V.A.C. Hyperlipidemia induced by Triton WR1339 (Tyloxapol) in Wistar rats. Rev. Bras. Cien. Med. Saúde. 2011, 1(1):32-34.
13. Janicki B.S., Aron S.A. Effect of Triton WR 1339 on lipoproteins and lipoprotein lipase of guinea pig plasma. Proc. Soc. Exp. Biol. Med. 1962, 109(March):507-509.
14. Phan T., Yu X.M., Kunnimalaiyaan M., Chen H. Antiproliferative effect of chrysin on anaplastic thyroid cancer. J. Surg. Res. 2011, 170(September (1)):84-88. (Epub 2011 April 20). 10.1016/j.jss.2011.03.064.
15. Pushpavalli G., Veeramani C., Pugalendi K.V. Influence of chrysin on hepatic marker enzymes and lipid profile against d-galactosamine-induced hepatotoxicity rats. Food Chem. Toxicol. 2010, 48(June (6)):1654-1659. (Epub 2010 March 31). 10.1016/j.fct.2010.03.040.
16. Sobocanec S., Sverko V., Balog T., Saric A., Rusak G., Likic S., Kusic B., Katalinic V., Radic S., Marotti T. Oxidant/antioxidant properties of Croatian native propolis. J. Agric. Food Chem. 2006, 54(October (21)):8018-8026.
17. Gambelunghe C., Rossi R., Sommavilla M., Ferranti C., Rossi R., Ciculi C., Gizzi S., Micheletti A., Rufini S.J. Effects of chrysin on urinary testosterone levels in human males. J. Med. Food. 2003, 6(Winter (4)):387-390.
18. Fu B., Xue J., Li Z., Shi X., Jiang B.H., Fang J. Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1alpha stability and inhibiting its protein synthesis. Mol. Cancer Ther. 2007, 6(1):220-226.
19. Critchfield J.W., Butera S.T., Folks T.M. Inhibition of HIV activation in latently infected cells by flavanoid compounds. AIDS Res. Hum. Retroviruses 1996, 12(January (1)):39-46.
20. Wolfman C., Violah P.A., Dajas F., Medina J.H. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol. Biochem. Behav. 1994, 47(January (1)):1-4.
21. Pearce F.L., Befus A.D., Bienenstock J. Mucosal mast cells. III. Effect of quercetin and other flavonoids on antigen-induced histamine secretion from rat intestinal mast cells. J. Allergy Clin. Immunol. 1984, 73(June (6)):819-823.
22. Machala M., Kubinova R., Suchy V. Chemoprotective potentials of homoisoflavonoids and chalcones of Dracaena cinnabari: modulations of drug metabolizing enzymes and antioxidant activity. Phytother. Res. 2001, 15(March (2)):114-118.
23. Li L., Wei D.-Q., Wang J.-F., Chou K.-C. Computational studies of the binding mechanism of calmodulin with chrysin. Biochem. Biophys. Res. Commun. 2007, 358(July (4)):1102-1107. (Epub 2007 May 22).
24. Ciftci O., Ozdemir I., Aydin M., Beytur A. Beneficial effects of chrysin on the reproductive system of adult male rats. Andrologia 2012, 44(June (3)):181-186. (Epub 2011 March 7). 10.1111/j.1439-0272.2010.01127.x.
25. Rocha J.T., Sperança A., Nogueira C.W., Zeni G. Hypolipidaemic activity of orally administered diphenyl diselenide in Triton WR-1339-induced hyperlipidaemia in mice. J. Pharm. Pharmacol. 2009, 61(December (12)):1673-1679. 10.1211/jpp/61.12.0013.
26. Sikarwar M.S., Patil M.B. Antihyperlipidemic activity of Salacia chinensis root extracts in Triton-induced and atherogenic diet-induced hyperlipidemic rats. Indian J. Pharmacol. 2012, 44(January (1)):88-92. 10.4103/0253-7613.91875.
27. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95(June (2)):351-358.
28. Reznick A.Z., Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 1994, 233:357-363.
29. Misra H.P., Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and simple assay for superoxide dismutase. J. Biol. Chem. 1972, 247(May (10)):3170-3175.
30. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
31. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82(May (1)):70-77.
32. Jacques-Silva M.C., Nogueira C.W., Broch L.C., J.B.T.Rocha J.B.T. Diphenyl diselenide and acorbic acid changes deposition of selenium and ascorbic acid in brain of mice. Pharmacol. Toxicol. 2001, 88(March (3)):119-125.
33. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
34. Xie W., Wang W., Su H., Xing D., Cai G., Du L. Hypolipidemic mechanisms of Ananas comosus L. leaves in mice: different from fibrates but similar to statins. J. Pharmacol. Sci. 2007, 103(March (3)):267-274.
35. Friedman M., Byers S.O. The mechanism responsible for the hypercholesteremia induced by Triton WR-1339. J. Exp. Med. 1953, 97(January (1)):117-130.
36. Goldfarb S. Rapid increase in hepatic HMG-CoA reductase activity and in vivo cholesterol synthesis after Triton WR 1339 injection. J. Lipid Res. 1978, 19(May (4)):489-494.
37. Johnston C. Functional foods as modifiers of cardiovascular disease. Am. J. Lifestyle Med. 2009, 3(July (1 Suppl.)):39S-43S.
38. Testai L., Martelli A., Cristofaro M., Breschi M.C., Calderone V. Cardioprotective effects of different flavonoids against myocardial ischaemia/reperfusion injury in Langendorff-perfused rat hearts. J. Pharm. Pharmacol. 2013, 65(May (5)):750-756. (Epub 2013 February 26). 10.1111/jphp.12032.
39. Lenfant C., Cleeman J.I., Ganiats T.G., Graham G., Kleinman R.E. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285(May (19)):2486-2497.
40. Schwab K.O., Doerfer J., Naeke A., Rohrer T., Wiemann D., Marg W., Hofer S.E., Holl R.W. Influence of food intake, age, gender, HbA1c, and BMI levels on plasma cholesterol in 29,979 children and adolescents with type 1 diabetes - reference data from the German diabetes documentation and quality management system (DPV). Pediatr. Diabetes 2009, 10(May (3)):184-192. (Epub 2008 October 10). 10.1111/j.1399-5448.2008.00469.x.
41. Kautzky-Willer A., Stich K., Hintersteiner J., Kautzky A., Kamyar M.R., Saukel J., Johnson J., Lemmens-Gruber R. Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study. Cardiovasc. Diabetol. 2013, May (12):78. 10.1186/1475-2840-12-78.
42. Anandhi R., Annadurai T., Anitha T.S., Muralidharan A.R., Najmunnisha K., Nachiappan V., Thomas P.A., Geraldine P. Antihypercholesterolemic and antioxidative effects of an extract of the oyster mushroom, Pleurotus ostreatus, and its major constituent, chrysin, in Triton WR-1339-induced hypercholesterolemic rats. J. Physiol. Biochem. 2013, 69:313-323.
43. Stokes K.Y., Cooper D., Tailor A., Granger D.N. Hypocholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic. Biol. Med. 2002, 33(October (8)):1026-1036.
44. Morgan M.J., Kim Y.S., Liu Z. Lipid rafts and oxidative stress-induced cell death. Antioxid. Redox Signal. 2007, 9(September (9)):1471-1483.
45. Rice-Evans C.A. Flavonoid antioxidants. Curr. Med. Chem. 2001, 8(June (7)):797-807.
46. Sirovina D., Oršolic N., Končic MZ, Kovačevic G., Benkovic V., Gregorovic G. Quercetin vs chrysin: effect on liver histopathology in diabetic mice. Human Exp. Toxicol. 2012, 1-9.
47. Hamelet J., Demluth K., Paul J.L., Delabar J.M., Janel N. Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice. J. Hepatol. 2007, 46(January (1)):151-159. (Epub 2006 September 22).
48. Novo E., Parola M. The role of redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogen. Tissue Repair 2012, 5(June (Suppl. 1)):S4.